| Literature DB >> 25418741 |
Kevin B Vargo1, Ajlan Al Zaki, Robert Warden-Rothman, Andrew Tsourkas, Daniel A Hammer.
Abstract
Recombinant surfactants present a new platform for stabilizing and targeting nanoparticle imaging agents. Superparamagnetic iron oxide nanoparticle-loaded micelles for MRI contrast are stabilized by an engineered variant of the naturally occurring protein oleosin and targeted using a Her2/neu affibody-oleosin fusion. The recombinant oleosin platform allows simple targeting and the ability to easily swap the ligand for numerous targets.Entities:
Keywords: MRI contrast; contrast agents; iron oxide; oleosin; recombinant surfactants; targeting
Mesh:
Substances:
Year: 2014 PMID: 25418741 PMCID: PMC4746475 DOI: 10.1002/smll.201402017
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281